摘要
目的:探讨链激酶静脉溶栓治疗急性心肌梗死的疗效。方法:在心电图监测下,对34例急性心肌梗死患者行链激酶静脉溶栓治疗。结果:冠脉再通22例,再通率达64.7%;未再通12例,其中病死2例,病死率为16.7%。不同时段溶栓时其并发症发生率明显不同(P<0.005)。结论:早期溶栓治疗可减少并发症,降低病死率。除1例高龄患者消化道出血外,未见其他严重不良反应。
Objective：To observe the efficacy of intravenous thrombolytic therapy of streptokinase on early acute myocardial infarction （AMI）. Methods： Thirty-four patients with AMI were treated by intravenous thrombolytic therapy of streptokinase under electrocardicgram monitoring. Results：The coronary reperfusions were observed in 22 cases,with a reperfusion rate of 64.7% and no reperfusion was found in 12 cases. Two patients died,with a mortality rate of 16.7%. The rates of complications during the different stages of thrombolytic therapy were significantly different（P〈0.005）. No severe side effect was found except that one dd patient developed digestive tract bleeding. Conclusions：Early application of thrombolytic therapy to AMI can decrease the complication and mortality rate.
出处
《蚌埠医学院学报》
CAS
2005年第5期419-420,共2页
Journal of Bengbu Medical College
关键词
心肌梗死
血栓溶解疗法
链激酶
myocardial irdarction
thrombolytic therapy
streptoktnase
